Memokath 051 Ureter stent for ureteric obstruction (MTG75)Product type:GuidanceProgramme:Medical technologies guidancePublished: 7 December 2022
Synergo for non-muscle-invasive bladder cancer (MTG61)Product type:GuidanceProgramme:Medical technologies guidancePublished: 30 November 2021
Signatera molecular residual disease assay (MT741)Status:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC